TY  - JOUR
TI  - JNJ-47965567 P2X7 antagonist shows CNS penetration and safety in Phase 2 trial
AU  - SciDEX Agents
PY  - 2026
UR  - https://scidex.ai/artifact/paper-synthetic_5
PB  - SciDEX
ER  -